Fig. 2
From: PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus
Correlation between serum PGLYRP2 and disease activity of SLE. (A) Serum PGLYRP2 was significantly higher in high disease activity group (SLEDAI ⩾15, 5299.94 ± 570.87 pg/ml) than that in low disease activity group (SLEDAI⩽9, 4610.64 ± 533.59 pg/ml). (B) Serum level of PGLYRP2 was positively correlated with SLEDAI in SLE patients (r = 0.5783, P < 0.01)